Note: Ingredients listed on restricted chemical lists
EC/CAS
500-038-2/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
50 - 75
EC/CAS
203-868-0/111-42-2
Name of the chemical
N,N-Diethanolamine (Ethanol, 2,2'-iminobis-)
Concentration
<3
EC/CAS
235-183-8/12124-97-9
Name of the chemical
Ammonium bromide
Concentration
<2.5
General Information
Version
4.0
Revision date
2023-06-07
Product name
CURA Heat Activated Flux 250g
supplier name
B.E.S. Ltd
Emergency telephone
+353 1 809 2566, +353 1 809 2166, 0344 892 0111, +44 845 880 60 50
Icons in SDS
Company Information
company name
B.E.S. Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
technical@bes.ltd.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H360, H362, H373, H412
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS08
Signal word
Danger
Contains
hydrobromic acid; 2,2'-iminodiethanol; diethanolamine; ammonium bromide
Hazard statements
H318 - Causes serious eye damage. H360 - May damage fertility or the unborn child. H362 - May cause harm to breast-fed children. H373 - May cause damage to organs through prolonged or repeated exposure. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P102 - Keep out of reach of children. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH210 - Safety data sheet available on request.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
